tyruko
sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - inmunosupresores - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 y 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.
aciclovir stada 50 mg/g crema efg
laboratorio stada s.l. - aciclovir - crema - 50 mg/g - aciclovir 50 mg - aciclovir
aciclovir vir 50 mg/g crema
industria quimica y farmaceutica vir s.a. - aciclovir - crema - 50 mg/g - aciclovir 50 mg - aciclovir
aciclovir viatris 50mg/g crema efg
viatris pharmaceuticals, s.l.u. - aciclovir - crema - 50 mg/g - aciclovir 50 mg - aciclovir
aciclovir normon 50 mg/g crema efg
laboratorios normon s.a. - aciclovir - crema - 50 mg/g - aciclovir 50 mg - aciclovir
aciclovir pensa 50 mg/g crema efg
towa pharmaceutical s.a. - aciclovir - crema - 50 mg/g - aciclovir 50 mg - aciclovir
aciclovir pharmagenus 50 mg/g crema efg
aristo pharma iberia s.l. - aciclovir - crema - 50 mg/g - aciclovir 50 mg - aciclovir
aciclovir sandoz care 50 mg/g crema
sandoz farmaceutica s.a. - aciclovir - crema - 50 mg/g - aciclovir 50 mg - aciclovir
aciclovir combix 50 mg/g crema efg
laboratorios combix s.l.u. - aciclovir - crema - 50 mg/g - aciclovir 50 mg - aciclovir
aciclovir kern pharma 50 mg/g crema efg
kern pharma s.l. - aciclovir - crema - 50 mg/g - aciclovir 50 mg - aciclovir